Common use of Insulin Clause in Contracts

Insulin. Pharmacists may interchange between short-acting and rapid-acting insulin products at equivalent dosing 1:1. Insulin glulisine (Apidra), insulin lispro (Humalog), regular human insulin (Humulin R), and insulin aspart (Novolog) Pharmacists may interchange between mixed insulin products at equivalent dosing 1:1. Insulin lispro/NPH (Humalog 75/25), regular human insulin/NPH (Humulin 70/30, Novolin 70/30), and insulin aspart/NPH (Novolog 70/30) Pharmacists may interchange between basal insulin products at equivalent dosing 1:1. Insulin glargine (Lantus, Basaglar, Toujeo), insulin detemir (Levemir), and insulin degludec (Tresiba) Standard dosing conversation (see Appendix 2.3.1)

Insulin.  Pharmacists may interchange between short-acting and rapid-acting insulin products at equivalent dosing 1:1.  Insulin glulisine (Apidra), insulin lispro (Humalog), regular human insulin (Humulin R), and insulin aspart (Novolog)  Pharmacists may interchange between mixed insulin products at equivalent dosing 1:1.  Insulin lispro/NPH (Humalog 75/25), regular human insulin/NPH (Humulin 70/30, Novolin 70/30), and insulin aspart/NPH (Novolog 70/30)  Pharmacists may interchange between basal insulin products at equivalent dosing 1:1.  Insulin glargine (Lantus, Basaglar, Toujeo), insulin detemir (Levemir), and insulin degludec (Tresiba)  Standard dosing conversation (see Appendix 2.3.1)